{"id":"W4293146062","doi":"10.2139/ssrn.4087355","title":"Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial","year":2022,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Joseph's Hospital","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Double blind; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Phase (matter); Internal medicine; Placebo; Alternative medicine; Virology; Outbreak; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002253589,0.002260257,0.004189333,0.0006435927,0.0006340671,0.001693915,0.001400947,0.002968233,0.01051231],"category_scores_gemma":[0.002470989,0.000918068,0.002997097,0.0006480545,0.00138415,0.001346568,0.0005551705,0.004394883,0.001525943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009499445,"about_ca_system_score_gemma":0.001720401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001412884,"about_ca_topic_score_gemma":0.002940901,"domain_scores_codex":[0.9990655,0.0004768492,0.00005999313,0.000149692,0.00007134457,0.0001766115],"domain_scores_gemma":[0.9989255,0.0003256882,0.0002313684,0.00007672653,0.0000597532,0.0003809305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9839895,0.002582829,0.0001833362,0.0007763254,0.0008115462,0.00003111839,0.0000357424,0.0001575169,0.001511586,0.0000983267,0.0008136577,0.009008556],"study_design_scores_gemma":[0.9778925,0.02083452,0.0004305292,0.0000365702,0.0002123728,0.0000176207,0.00001127862,0.00009917499,0.00008048349,0.00006694064,0.0003082959,0.000009721518],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9501081,0.02552443,0.001850783,0.002052169,0.002516486,0.009616528,0.003018674,0.0003881836,0.004924695],"genre_scores_gemma":[0.9600705,0.01225449,0.004064162,0.002990798,0.001162857,0.01060202,0.00275699,0.00008728918,0.006011018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01051231,"threshold_uncertainty_score":0.03516722,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0706981100000122,"score_gpt":0.4489419790187258,"score_spread":0.3782438690187137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}